Nathalie de Jaeger

Nathalie de Jaeger is a seasoned professional in the pharmaceutical industry, currently serving as Déléguée Hospitalière Expert VIH at ViiV Healthcare since February 2023. With extensive experience in various therapeutic areas, Nathalie has held roles such as Attachée Scientifique Régionale at Almirall, where responsibilities included launching Tildrakizumab for psoriasis, and Déléguée Hospitalière in hematology at Janssen, focusing on the introduction of Imbruvica and Daratumumab. Prior engagements span multiple reputable companies, including Shire Pharmaceuticals, Nycomed, Allergan, and AstraZeneca, where Nathalie demonstrated expertise in oncology, neurology, psychiatry, and dermatology. Educational credentials include a Diplôme Visite Médicale from Expand Prépa Santé and a Deug in Biologie from Faculté Paris XII. Nathalie has been an active member of the Cercle des Gens Bien & Bienveillants since January 2020, reflecting a commitment to professional development and community engagement.